BAT nicotine inhaler licensed as medicinal product in UK
LONDON, Sept 12 (Reuters) - A new nicotine inhaler to be sold by a unit of British American Tobacco (LSE: BATS.L - news) has been licensed in the UK as a medicinal product, marking the arrival of a new competitor in the fast-growing electronic cigarette market.
The Voke Inhaler contains no electronics, heat or combustion and is designed to rival both e-cigarettes and nicotine-replacement therapies, such as gum and patches.
The product was developed by Kind Consumer, working with Consort Medical (Other OTC: CSRMY - news) , and the next step will be to submit a variation to the licence granted by the Medicines and Healthcare products Regulatory Agency (MHRA) to support full-scale commercialisation by BAT's Nicoventures, the companies said.
(Reporting by Ben Hirschler, Editing by Paul Sandle)